SavedAdd your journal

Journals / Southern Clinics of Istanbul Eurasia / 2022 / Cilt: 33 - Sayı: 1

Influences of Uterine Adenomyosis On Pathologic Prognostic Characteristics and Survival Time in Patients with Endometrial Cancer

Emre MAT
Mustafa GÖKKAYA
Gazi YILDIZ
Melike YAVUZ
Mehmet Mustafa ALTINTAŞ
Betül KURU
Gülfem BAŞOL
Elif Cansu GÜNDOĞDU
Navdar Doğuş UZUN
Taner A USTA
Ahmet KALE
Pages
51–58
Publication Date
2022-10-19
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Overall survival (OS) was similar between patients with and without AM (Cox regression Wald=0.654, p=0.419).

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objective: The first aim of the present study was to investigate whether the presence of adenomyosis (AM) had an effect on pathologic prognostic characteristics and survival time in patients with endometrial carcinoma (EC).
📊
Key Findings & Data:Results: A total of 518 endometrial cancer patients were analyzed.
💡
Conclusion & Impact:Overall survival (OS) was similar between patients with and without AM (Cox regression Wald=0.654, p=0.419).
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Objective: The first aim of the present study was to investigate whether the presence of adenomyosis (AM) had an effect on pathologic prognostic characteristics and survival time in patients with endometrial carcinoma (EC). The second aim was to evaluate the association of AM for each subtype grouping as low-grade endometrioid carcinoma, high-grade endometrioid carcinoma, and high-grade non-endometrioid carcinoma. Methods: The present retrospective observational cohort study was conducted using the institution’s database of patients with EC who underwent staging surgery. The cohort was divided into two groups according to the presence or absence of AM. Additionally, EC subtypes were grouped into low-grade endometrioid, high-grade endometrioid, and high-grade non-endometrioid tumors according to the presence or absence of AM as well. The survival outcomes and pathologic prognostic characteristics were compared between the groups. Results: A total of 518 endometrial cancer patients were analyzed. Overall survival (OS) was similar between patients with and without AM (Cox regression Wald=0.654, p=0.419). In multivariate Cox regression analysis, the presence of AM was not associated with survival time (p=0.378). However, histologic type with grade, lymph vascular space invasion, and metastasis were significant factors predicting the survival time (endometrioid low grade vs endometrioid high grade, p1=0.075 and endometrioid low grade vs non-endometrioid high grade, p2=0.020; p=0.001 and p=0.001, respectively). Survival means for survival time in patients with and without AM in different histologic types with grade was similar for each subgroup (p>0.005 for each group). Conclusion: Our findings indicated that the presence of AM with EC is not an independent prognostic factor for OS.

🔖

Cite This Article

MAT, E., GÖKKAYA, M., YILDIZ, G., YAVUZ, M., ALTINTAŞ, M. M., KURU, B., BAŞOL, G., GÜNDOĞDU, E. C., UZUN, N. D., USTA, T. A., KALE, A. (2022). Influences of Uterine Adenomyosis On Pathologic Prognostic Characteristics and Survival Time in Patients with Endometrial Cancer. Southern Clinics of Istanbul Eurasia, Cilt: 33 - Sayı: 1, 51–58. https://ajindex.com/articles/592721

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (13)

  1. Siegel RL, Miller KD, Jemal A. Cancer statistics. Cancer J Clin 2020;70:7–30
  2. Ferlay J, Soerjomataram I, Dikshit R, Eser S, Mathers C, Rebelo M, et al. Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer 2015;136:359–86
  3. Nakamura K, Nakayama K, Ishikawa N, Minamoto T, Ishibashi T, Ohnishi K, et al. Preoperative tumor size is associated with deep myometrial invasion and lymph node metastases and is a negative prognostic indicator for patients with endometrial carcinoma. Oncotarget 2018;9:23164–72
  4. Singh N, Hirschowitz L, Zaino R, Alvarado-Cabrero I, Duggan MA, Ali-Fehmi R, et al. Pathologic prognostic factors in endometrial carcinoma (other than tumor type and grade). Int J Gynecol Pathol 2019;38 Suppl 1:S93–S113
  5. Bokhman JV. Two pathogenetic types of endometrial carcinoma. Gynecol Oncol 1983;15:10–7
  6. Yang HP, Wentzensen N, Trabert B, Gierach GL, Felix AS, Gunter MJ, et al. Endometrial cancer risk factors by 2 main histologic sub types: the NIH-AARP Diet and Health Study. Am J Epidemiol 2013;177:142–51
  7. Bergeron C, Amant F, Ferenczy A. Pathology and physiopathology of adenomyosis. Best Pract Res Clin Obstet Gynaecol 2006;20:511–21
  8. Musa F, Frey MK, Im HB, Chekmareva M, Ellenson LH, Holcomb K. Does the presence of adenomyosis and lymphovascular space invasion affect lymph node status in patients with endometrioid adenocarcinoma of the endometrium? Am J Obstet Gynecol 2012;207:417.e1–6
  9. Gizzo S, Patrelli TS, Dall’asta A, Di Gangi, S., Giordano G, Migliavacca C, et al. Coexistence of adenomyosis and endometrioid endometrial cancer: Role in surgical guidance and prognosis estimation. Oncol Lett 2016;11:1213–9
  10. Tetikkurt S, Çelik E, Taş H, Cay T, Işik S, Usta AT. Coexistence of adenomyosis, adenocarcinoma, endometrial and myometrial lesions in resected uterine specimens. Mol Clin Oncol 2018;9:231–7
  11. Zhang Z, Yang B, Zhang W, Gao X, Zhao C, Zhang X. Correspondence to ‘Clinicopathological characteristics and survival outcomes of patients with coexistence of adenomyosis and endometrial carcinoma’. Int J Clin Exp Pathol 2018;11:3825–6
  12. Ismiil N, Rasty G, Ghorab Z, Nofech-Mozes S, Bernardini M, Ackerman I, et al. Adenomyosis involved by endometrial adenocarcinoma is a significant risk factor for deep myometrial invasion. Ann Diagn Pathol 2007;11:252–7
  13. Seidman, J. D, Jeffrey D, Kjerulff, Kristen H. Pathologic findings from the Maryland Women’s Health Study: pra